[Federal Register Volume 63, Number 1 (Friday, January 2, 1998)]
[Notices]
[Page 61]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-34201]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent to Grant Exclusive Patent License; U.S. Drug
Testing, Inc.
AGENCY: Department of the Navy, DoD.
ACTION: Notice of intent to grant exclusive license.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to U.S. Drug Testing, Inc., a revocable, nonassignable,
exclusive license in the United States and certain foreign countries to
practice the Government owned invention described in U.S. Patent No.
5,183,740, entitled ``Flow Immunosensor Method and Apparatus,'' issued
February 2, 1993, in the field of saliva based human diagnostics.
DATES: Anyone wishing to object to the grant of this license must file
written objections, along with any supporting evidence, not later than
March 3, 1998.
ADDRESSES: Written objections are to be filed with the Office of Naval
Research, ONR 00CC, Ballston Tower One, 800 North Quincy Street,
Arlington, Virginia 22217-5660.
FOR FURTHER INFORMATION CONTACT:
Mr. R. J. Erickson, Staff Patent Attorney, Office of Naval Research,
ONR 00CC, Ballston Tower One, 800 North Quincy Street, Arlington,
Virginia 22217-5660, telephone (703) 696-4001.
Authority: 35 U. S. C. 207; 37 CFR Part 404; 32 CFR Part 746.
Dated: December 19, 1997.
Michael I. Quinn,
Lieutenant Commander, Judge Advocate General's Corps, U. S. Navy,
Alternate Federal Register Liaison Officer.
[FR Doc. 97-34201 Filed 12-31-97; 8:45 am]
BILLING CODE 3810-FF-P
